新宙邦(300037.SZ)一季度淨利潤預降48.20%-57.98%
格隆匯3月27日丨新宙邦(300037.SZ)公佈,預計2023年一季度歸屬於上市公司股東的淨利潤2.15億元-2.65億元,同比下降48.20%-57.98%;扣除非經常性損益後的淨利潤1.995億元-2.495億元,同比下降50.40%-60.34%。
報吿期內,公司電池化學品業務面臨春節假期延長、下游客户開工不足的複雜局面,雖然公司堅持穩住市場份額的經營策略,但受上述因素影響,出貨量不及預期,疊加新能源汽車產業鏈供給需求關係變化的影響,銷售價格同比大幅下降,銷售額同比下降;公司有機氟化學品業務市場需求旺盛,銷售增長較快。
報吿期公司非經常性損益約1550萬元,比上年同期增加約687萬元,主要形成原因是政府補助收益以及理財收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.